EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An in utero exposure to the synthetic estrogen diethylstilbestrol affects the fat pad composition in post-natal mammary glands

David Tovar-Parra iD, Alec McDermott, Jysiane Cardot, Melany Nicole Juarez, Fabien Joao, Rhizlane El Omri-Charai, Line Berthiaume, Bhawna Dhawan, Arash Aghigh, Yann Breton, François Légaré, Géraldine Delbès iD und 3 weitere

Toxicological Sciences · 2026

DOI: 10.1093/toxsci/kfaf157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2026. Verfasst von David Tovar-Parra und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Recherche Scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Laval, QC H7V 1B7, Canada. Hauptthemen laut MEDLINE: Diethylstilbestrol, Mammary Glands, Animal, Prenatal Exposure Delayed Effects, Adipose Tissue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: de recherche du Quebec, Nature et technologie, National Sciences and Engineering Research Council of Canada, Réseau Québecois en reproduction, Armand-Frappier scholarships and FRQS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In utero exposure to the synthetic estrogen diethylstilbestrol (DES) has been linked to developmental abnormalities and elevated breast cancer risk in adulthood in human and rodent models. Although the impact of DES on the mammary epithelium has been thoroughly investigated, its effect on the other cell types of the mammary gland remains understudied. Here, given that the mammary gland development is strongly associated with its microenvironment, we aimed to investigate how in utero DES exposure alters the mammary gland’s stromal and immune function across key developmental stages. To achieve this aim, timed-pregnant rats were gavaged daily with DES or vehicle from gestation days 16 to 21, and female offspring mammary glands were analyzed at pre-puberty (postnatal day 21 [PND21]), puberty (PND46), and adulthood (PND90). We assessed morphological and extracellular matrix changes, performed transcriptomic cell-type enrichment analysis, measured cytokine expression, and quantified immune cell populations. DES-exposed mammary glands exhibited pronounced stromal remodeling, including increased collagen deposition and orientation by adulthood. Gene expression profiling indicated DES-induced stage-specific immune alterations: Immune cell signatures were enriched at PND21 and PND90 but diminished at PND46. Correspondingly, DES increased macrophage populations at PND21 while reducing T-lymphocyte numbers at PND46 and PND90. DES exposure also dysregulated inflammatory cytokine/chemokine expression in adult glands, suggesting a persistent inflammatory environment. In conclusion, in utero exposure to an estrogenic compound can reprogram mammary development, inducing long-term changes in the extracellular matrix and immune landscape. These disruptions to stromal-immune homeostasis may impair normal mammary morphogenesis and increase susceptibility to breast pathologies later in life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiethylstilbestrolMammary Glands, AnimalPrenatal Exposure Delayed EffectsAdipose TissueEstrogens, Non-SteroidalEstrogensAnimalsFemalePregnancyRatsRats, Sprague-Dawley

Stichwörter der Autor:innen

developmentdiethylstilbestrolgestational exposureimmune cellsmammary gland

Substanzen

DiethylstilbestrolEstrogens, Non-SteroidalEstrogens

Autor:innen und Institutionen

  • Institut National de la Recherche Scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Laval, QC H7V 1B7, Canada.
  • Axe Endocrinologie-Néphrologie, Centre de recherche du CHU de Québec-Université Laval, Quebec, QC G1V 4G2, Canada.
  • Centre de recherche en reproduction, développement et santé intergénérationnelle (CRDSI) de l'Université Laval, Quebec, QC G1V 4G2, Canada.
  • Institut National de la Recherche Scientifique (INRS) Centre Énergie Matériaux Télécommunications, Varennes, QC J3X 1P7, Canada.
  • Axe Maladies infectieuses et immunitaires, Centre de recherche du CHU de Québec-Université Laval, Quebec, QC G1V 4G2, Canada.
  • Arthritis Research Center, Laval University, Quebec, QC G1V 4G2, Canada.

ORCID-Profile: David Tovar-Parra, Géraldine Delbès, Martin Pelletier, Isabelle Plante

Förderung

  • de recherche du Quebec, Nature et technologie
  • National Sciences and Engineering Research Council of Canada
  • Réseau Québecois en reproduction, Armand-Frappier scholarships and FRQS

Zitieren

APA

Tovar-Parra, D., McDermott, A., Cardot, J., Juarez, M. N., Joao, F., El Omri-Charai, R., Berthiaume, L., Dhawan, B., Aghigh, A., Breton, Y., Légaré, F., Delbès, G., Pelletier, M., Audet-Walsh, É., & Plante, I. (2026). An in utero exposure to the synthetic estrogen diethylstilbestrol affects the fat pad composition in post-natal mammary glands. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf157

Vancouver

Tovar-Parra D, McDermott A, Cardot J, Juarez MN, Joao F, El Omri-Charai R, et al. An in utero exposure to the synthetic estrogen diethylstilbestrol affects the fat pad composition in post-natal mammary glands. Toxicological Sciences. 2026. doi:10.1093/toxsci/kfaf157

BibTeX
@article{TovarParra2026,
  author = {Tovar-Parra, David and McDermott, Alec and Cardot, Jysiane and Juarez, Melany Nicole and Joao, Fabien and El Omri-Charai, Rhizlane and Berthiaume, Line and Dhawan, Bhawna and Aghigh, Arash and Breton, Yann and Légaré, François and Delbès, Géraldine and Pelletier, Martin and Audet-Walsh, Étienne and Plante, Isabelle},
  title = {An in utero exposure to the synthetic estrogen diethylstilbestrol affects the fat pad composition in post-natal mammary glands},
  journal = {Toxicological Sciences},
  year = {2026},
  doi = {10.1093/toxsci/kfaf157}
}
Kostenlos starten →